Skip to main content
Clinical Trials/NCT04976517
NCT04976517
Unknown
Not Applicable

A Multicenter Clinical Study of Echocardiographic Evaluation of the Impact of Diabetes and Prognostic Analysis of Heart Transplantation

Xie Mingxing0 sites1,500 target enrollmentAugust 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Transplant
Sponsor
Xie Mingxing
Enrollment
1500
Primary Endpoint
all-cause mortality
Last Updated
4 years ago

Overview

Brief Summary

The aim of this study is to evaluat the impact of diabetes on cardiac function in patients with heart transplantation by multimodal imaging and analyse their prognosis.

Detailed Description

This study is planed to enroll 300000 patients after heart transplantation, all the patients will be divided into 3 groups according to whether or not they have diabetes and when did they develop diabete. Echocardiography will be used to evaluat their cardiac function. Comparing their cardiac function and clinical information and analysing their prognosis to evaluat the impact of diabetes.

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
March 31, 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Xie Mingxing
Responsible Party
Sponsor Investigator
Principal Investigator

Xie Mingxing

MD, PhD,FACC, FAHA, FASE

Wuhan Union Hospital, China

Eligibility Criteria

Inclusion Criteria

  • Adult patients who received a heart transplant after 2015

Exclusion Criteria

  • The image quality is poor

Outcomes

Primary Outcomes

all-cause mortality

Time Frame: up to 2023.12

death from all causes

readmission

Time Frame: up to 2023.12

readmission from all causes

acute rejection

Time Frame: up to 2023.12

acute rejection required treatment

Similar Trials